In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles

Annie Sciacca / kffhealthnews - Conservative Shasta County stopped a measles outbreak from spreading, enlisting teachers, church leaders, and other trusted community members to get the public on board with health guidelines. Infectious disease specialists say the successful effort could…

AI Summary: Public health teams in a vaccine-hesitant California county deployed a targeted containment strategy—rapid case isolation, focused vaccination drives, community outreach and tailored messaging—to curb a measles flare-up. The approach balanced enforcement and engagement, showing that pragmatic, locally adapted tactics can control outbreaks even where vaccine acceptance is low.

U.S. Government Will Stop Paying for Test Strips to Detect Deadly Drugs

Jan Hoffman / nytimes - In a letter to states and other grant recipients, the Trump administration says the strips encourage drug use.

AI Summary: Public health officials have declared the South Carolina measles outbreak over after nearly 1,000 people fell ill, attributing containment to intensified vaccination campaigns and contact tracing. Authorities warn that immunity gaps still exist and stressed that preventable outbreaks will recur without sustained immunization efforts — a blunt reminder that vaccines remain the easiest way to avoid headline-making contagions.

Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial

Kristin Jensen / healthcaredive - A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.

AI Summary: Moderna has initiated a clinical trial of an mRNA vaccine targeting a potentially pandemic bird‑flu strain, joining global efforts to have a rapid‑response countermeasure ready. Regulators and public‑health experts hail the move as sensible pre‑emptive science—because nothing says “we planned for this” like testing the vaccine before the outbreak arrives.

Too young for the MMR shot, babies become 'sitting ducks' in measles outbreaks

medicalxpress - With baby Arthur too young for the measles vaccine and a sibling due in June, the Otwells grew nervous when the threat of the highly contagious virus started factoring into their grocery run.

AI Summary: Health reporting highlights that infants below the eligible age for the MMR vaccine remain highly vulnerable during measles outbreaks, effectively "sitting ducks" until immunization is possible. Public-health experts warn that gaps in community immunity and outbreak control measures disproportionately endanger these youngest children, underscoring the need for stronger herd-protection and targeted outbreak responses.

RFK Jr. launching health podcast to expose ‘hypocrisy’ and ‘corruption’

fiercehealthcare - Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services (HHS) secretary framed the podcast as a response to public health problems that he said have made “many of us ... come to the conc…

AI Summary: Robert F. Kennedy Jr. is debuting a health-focused podcast promising to call out what he characterizes as hypocrisy and corruption in medicine and public health. The show aims to amplify skeptical takes on mainstream health institutions and policies, positioning itself as a combative platform for contrarian voices and investigations.

Pfizer Lyme vaccine candidate heads to FDA

Ella Jeffries / beckershospitalreview - Pfizer and Valneva’s investigational Lyme disease vaccine candidate, PF-07307405 (LB6V), demonstrated more than 70% efficacy in preventing Lyme disease among individuals age 5 and older, according to topline phase 3 trial results. The prespecified analysi…

AI Summary: Pfizer is advancing a Lyme disease vaccine toward FDA submission despite a messy late‑stage picture: efficacy signals above 70% were reported while a pivotal trial missed its primary endpoint and struggled with low case numbers. Regulators must weigh public health need against statistical nuance as the company pushes for licensure.

This common vaccine cuts heart risk nearly in half in new study

sciencedaily - A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications …

AI Summary: New research finds that receipt of a common shingles vaccine is associated with roughly a 50% reduction in serious cardiac events in the studied population. Investigators propose immune‑modulating mechanisms may underlie the protective effect; if confirmed, the vaccine could offer a tidy twofer—preventing shingles and cutting heart risk—proof that prevention sometimes moonlights as cardiology.

Measles outbreaks could fuel rise in fatal complication, physicians warn

Mackenzie Bean / beckershospitalreview - As measles continues spreading across the U.S. at a pace not seen in decades, physicians are warning about a rare but often fatal neurological complication that can emerge years after initial infection, KFF Health News reported March 13. Subacute sclerosi…

AI Summary: Measles is resurging across the United States at levels not seen in decades, and clinicians warn this spike could drive an increase in a rare but often fatal neurological complication. Public‑health experts point to falling vaccination coverage and gaps in outbreak control as the drivers, urging renewed immunization efforts and vigilance.

Flu vaccines didn't work that well in the US, officials find

medicalxpress - As the U.S. flu season winds down, health officials say the flu vaccine didn't work very well, with one of its worst effectiveness rates in more than a decade.

AI Summary: Health officials report this season’s influenza vaccine performed poorly, with effectiveness among the lowest in recent years. A mismatch between vaccine strains and circulating viruses reduced protection, prompting calls for strain updates ahead of the fall program. Public health leaders still urge vaccination for partial protection and to blunt severe outcomes.

Severe COVID or Severe Flu May Raise Risk of Lung Cancer, But Vaccines Helped in Animal Tests

discovermagazine - Learn how severe respiratory illness leaves the lungs vulnerable to cancer, and how vaccines could prevent these vulnerabilities.

AI Summary: New animal and observational evidence suggests severe respiratory infections—including serious COVID‑19 and influenza—can prime lung tissue and accelerate cancer development months to years later. Vaccination appeared to blunt those effects in experimental models, highlighting prevention as a potential cancer‑risk reduction strategy and urging clinicians to watch survivors of severe infections more closely.

FDA Transparency Push Expands to Monitoring Safety of Vaccines and Other Regulated Products

Frank Vinluan / medcitynews - The FDA said consolidating safety reporting into a single platform, the Adverse Event Monitoring System (AEMS), will increase transparency and reduce costs. But like the legacy systems it replaces, AEMS reports are unverified so causation and frequency of…

AI Summary: The FDA is consolidating multiple safety reporting systems into a single public Adverse Event Monitoring System to centralize reports for drugs, biologics, vaccines, cosmetics and animal products. The move aims to improve transparency, reduce fragmented reporting, and streamline monitoring — a tidy solution if it works as promised.

FDA vaccine chief to step down in April

Ella Jeffries / beckershospitalreview - Vinay Prasad, MD, the FDA’s top regulator of vaccines and cell and gene therapies, will step down at the end of April, an agency spokesperson confirmed to Becker’s. Dr. Prasad joined the agency in 2025 on a one-year sabbatical from the University of Calif…

AI Summary: Vinay Prasad, the FDA’s top regulator for vaccines and cell and gene therapies, will step down at the end of April amid mounting criticism over controversial decisions that reportedly overrode agency scientists and spooked stakeholders. His exit follows prolonged internal and external disputes about regulatory judgment and leadership style.

RFK Jr. names 2 new members to CDC vaccine panel

Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…

AI Summary: HHS Secretary Robert F. Kennedy Jr. appointed two clinicians to the CDC’s Advisory Committee on Immunization Practices just weeks before a rescheduled session, installing new voting members ahead of vaccine deliberations. The last‑minute nominations aim to ensure the panel is fully staffed for upcoming guidance discussions.

A novel C. diff vaccine shows promise

Mariah Taylor / beckershospitalreview - Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary toxins, according to a Feb. 18 system news release. Th…

AI Summary: Researchers at Vanderbilt have reported a novel experimental vaccine that prevents Clostridioides difficile infection and reduces recurrence in early studies, demonstrating strong protective immune responses. The work offers a much‑needed alternative to antibiotics and recurrent‑infection management, though larger clinical trials will be required to confirm safety, durability and real‑world impact.

CDC confirms 910 measles cases in 2026; South Carolina remains hardest hit

Paige Twenter / beckershospitalreview - Six weeks into 2026, the CDC has confirmed 910 measles cases. If the pace of transmission continues, this year could far outpace the 2,280 cases detected across the U.S. in 2025, as 2026’s total is already 40% of 2025’s. The hardest-hit state is South Car…

AI Summary: The CDC has confirmed a nationwide uptick in measles cases, tallying hundreds of infections and triggering local public-health responses. Hotspots include a large South Carolina outbreak, an over‑40‑case cluster at a Florida college and a Los Angeles County case involving visits to LAX eateries while infectious. Officials urge vaccination and vigilance.

'Universal' nasal-spray vaccine protects against viruses, bacteria and allergens in mice

livescience - In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, scientists report.

AI Summary: Scientists reported a nasal-spray vaccine that protected mice against a range of respiratory viruses, bacteria and even a common allergen, a tantalizing step toward a universal respiratory vaccine. The animal data look promising, but human trials are essential before anyone ditches annual shots for a single spritz and a prayer.